vs

Side-by-side financial comparison of ILLUMINA, INC. (ILMN) and UGI CORP (UGI). Click either name above to swap in a different company.

UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.1B, roughly 1.9× ILLUMINA, INC.). UGI CORP runs the higher net margin — 14.4% vs 12.3%, a 2.1% gap on every dollar of revenue. On growth, ILLUMINA, INC. posted the faster year-over-year revenue change (4.8% vs 3.9%). ILLUMINA, INC. produced more free cash flow last quarter ($251.0M vs $-155.0M). Over the past eight quarters, ILLUMINA, INC.'s revenue compounded faster (-1.3% CAGR vs -7.5%).

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.

ILMN vs UGI — Head-to-Head

Bigger by revenue
UGI
UGI
1.9× larger
UGI
$2.1B
$1.1B
ILMN
Growing faster (revenue YoY)
ILMN
ILMN
+0.9% gap
ILMN
4.8%
3.9%
UGI
Higher net margin
UGI
UGI
2.1% more per $
UGI
14.4%
12.3%
ILMN
More free cash flow
ILMN
ILMN
$406.0M more FCF
ILMN
$251.0M
$-155.0M
UGI
Faster 2-yr revenue CAGR
ILMN
ILMN
Annualised
ILMN
-1.3%
-7.5%
UGI

Income Statement — Q1 FY2027 vs Q1 FY2026

Metric
ILMN
ILMN
UGI
UGI
Revenue
$1.1B
$2.1B
Net Profit
$134.0M
$297.0M
Gross Margin
66.1%
Operating Margin
19.2%
22.0%
Net Margin
12.3%
14.4%
Revenue YoY
4.8%
3.9%
Net Profit YoY
-20.8%
EPS (diluted)
$0.87
$1.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILMN
ILMN
UGI
UGI
Q1 26
$1.1B
Q4 25
$1.2B
$2.1B
Q3 25
$1.2B
Q2 25
$1.4B
Q1 25
$2.6B
Q4 24
$1.1B
$2.0B
Q3 24
$1.1B
$1.2B
Q2 24
$1.1B
$1.4B
Net Profit
ILMN
ILMN
UGI
UGI
Q1 26
$134.0M
Q4 25
$334.0M
$297.0M
Q3 25
$-13.0M
Q2 25
$-163.0M
Q1 25
$479.0M
Q4 24
$186.0M
$375.0M
Q3 24
$705.0M
$-273.0M
Q2 24
$-2.0B
$-48.0M
Gross Margin
ILMN
ILMN
UGI
UGI
Q1 26
66.1%
Q4 25
65.5%
Q3 25
Q2 25
Q1 25
Q4 24
65.9%
Q3 24
69.0%
Q2 24
64.8%
Operating Margin
ILMN
ILMN
UGI
UGI
Q1 26
19.2%
Q4 25
17.4%
22.0%
Q3 25
1.1%
Q2 25
-6.8%
Q1 25
26.6%
Q4 24
15.8%
24.5%
Q3 24
68.6%
-20.4%
Q2 24
-147.2%
5.0%
Net Margin
ILMN
ILMN
UGI
UGI
Q1 26
12.3%
Q4 25
28.8%
14.4%
Q3 25
-1.1%
Q2 25
-12.0%
Q1 25
18.2%
Q4 24
16.8%
18.9%
Q3 24
65.3%
-22.6%
Q2 24
-178.8%
-3.6%
EPS (diluted)
ILMN
ILMN
UGI
UGI
Q1 26
$0.87
Q4 25
$2.16
$1.34
Q3 25
$-0.08
Q2 25
$-0.76
Q1 25
$2.19
Q4 24
$1.16
$1.74
Q3 24
$4.42
$-1.26
Q2 24
$-12.48
$-0.23

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILMN
ILMN
UGI
UGI
Cash + ST InvestmentsLiquidity on hand
$1.2B
$251.0M
Total DebtLower is stronger
$6.0B
Stockholders' EquityBook value
$2.7B
$5.0B
Total Assets
$6.6B
$15.8B
Debt / EquityLower = less leverage
1.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILMN
ILMN
UGI
UGI
Q1 26
$1.2B
Q4 25
$1.6B
$251.0M
Q3 25
$335.0M
Q2 25
$350.0M
Q1 25
$426.0M
Q4 24
$93.0M
$240.0M
Q3 24
$70.0M
$213.0M
Q2 24
$74.0M
$183.0M
Total Debt
ILMN
ILMN
UGI
UGI
Q1 26
Q4 25
$6.0B
Q3 25
$6.5B
Q2 25
$5.7B
Q1 25
$6.6B
Q4 24
$6.6B
Q3 24
$6.4B
Q2 24
$6.3B
Stockholders' Equity
ILMN
ILMN
UGI
UGI
Q1 26
$2.7B
Q4 25
$2.7B
$5.0B
Q3 25
$4.8B
Q2 25
$4.9B
Q1 25
$5.0B
Q4 24
$2.4B
$4.6B
Q3 24
$2.1B
$4.3B
Q2 24
$1.4B
$4.7B
Total Assets
ILMN
ILMN
UGI
UGI
Q1 26
$6.6B
Q4 25
$6.6B
$15.8B
Q3 25
$15.5B
Q2 25
$15.4B
Q1 25
$15.7B
Q4 24
$6.3B
$15.4B
Q3 24
$6.0B
$15.1B
Q2 24
$6.1B
$15.1B
Debt / Equity
ILMN
ILMN
UGI
UGI
Q1 26
Q4 25
1.19×
Q3 25
1.37×
Q2 25
1.17×
Q1 25
1.32×
Q4 24
1.44×
Q3 24
1.48×
Q2 24
1.34×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILMN
ILMN
UGI
UGI
Operating Cash FlowLast quarter
$289.0M
$66.0M
Free Cash FlowOCF − Capex
$251.0M
$-155.0M
FCF MarginFCF / Revenue
23.0%
-7.5%
Capex IntensityCapex / Revenue
10.7%
Cash ConversionOCF / Net Profit
2.16×
0.22×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$282.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILMN
ILMN
UGI
UGI
Q1 26
$289.0M
Q4 25
$321.0M
$66.0M
Q3 25
$90.0M
Q2 25
$289.0M
Q1 25
$684.0M
Q4 24
$364.0M
$164.0M
Q3 24
$316.0M
$151.0M
Q2 24
$80.0M
$390.0M
Free Cash Flow
ILMN
ILMN
UGI
UGI
Q1 26
$251.0M
Q4 25
$267.0M
$-155.0M
Q3 25
$-168.0M
Q2 25
$67.0M
Q1 25
$538.0M
Q4 24
$335.0M
$-47.0M
Q3 24
$284.0M
$-115.0M
Q2 24
$49.0M
$185.0M
FCF Margin
ILMN
ILMN
UGI
UGI
Q1 26
23.0%
Q4 25
23.0%
-7.5%
Q3 25
-14.4%
Q2 25
4.9%
Q1 25
20.4%
Q4 24
30.3%
-2.4%
Q3 24
26.3%
-9.5%
Q2 24
4.4%
13.7%
Capex Intensity
ILMN
ILMN
UGI
UGI
Q1 26
Q4 25
10.7%
Q3 25
22.1%
Q2 25
16.3%
Q1 25
5.5%
Q4 24
2.6%
10.6%
Q3 24
3.0%
22.0%
Q2 24
2.8%
15.2%
Cash Conversion
ILMN
ILMN
UGI
UGI
Q1 26
2.16×
Q4 25
0.96×
0.22×
Q3 25
Q2 25
Q1 25
1.43×
Q4 24
1.96×
0.44×
Q3 24
0.45×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ILMN
ILMN

Product revenue$917.0M84%
Service and other revenue$174.0M16%

UGI
UGI

Segment breakdown not available.

Related Comparisons